Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of large B-cells in lymph nodes at multiple sites. It is clinically significant due to its aggressive nature and potential for widespread disease. Accurate coding with ICD-10 Code C83.38 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code C83.38 represents Diffuse large B-cell lymphoma affecting lymph nodes in multiple sites. This code is used when documenting cases of DLBCL that do not fall under more specific classifications. It is crucial for accurate clinical documentation and billing, particularly when managing patients with this aggressive form of lymphoma.
Diffuse large B-cell lymphoma is a hematological malignancy that arises from B-lymphocytes and is characterized by the presence of large, atypical cells. The condition can progress rapidly, leading to significant morbidity and mortality if not treated promptly. Medical attention is critical for diagnosis and management.
ICD-10 Code C83.38 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management strategies.
In SOAP notes, ICD-10 Code C83.38 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Diffuse large B-cell lymphoma. This coding ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Diffuse large B-cell lymphoma requires urgent medical intervention, often necessitating hospitalization for intensive treatment. Standard approaches include chemotherapy and, in some cases, radiation therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.38 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 96415 | Chemotherapy administration, intravenous, infusion technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count with differential. |
Common Questions About Using ICD-10 Code C83.38 for Diffuse large B-cell lymphoma, lymph nodes of multiple sites
What are the common symptoms of Diffuse large B-cell lymphoma?
Common symptoms include painless swelling of lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and loss of appetite.
How is Diffuse large B-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of large B-cells.
What treatments are available for Diffuse large B-cell lymphoma?
Treatment usually involves chemotherapy, often in combination with immunotherapy. Radiation therapy may also be used in certain cases, depending on the extent of the disease.
Is Diffuse large B-cell lymphoma curable?
Diffuse large B-cell lymphoma can be curable, especially if diagnosed early and treated promptly. The prognosis varies based on several factors, including the patient's age and overall health.
Clinical Notes
SOAP notes
DAP notes
AI medical notes